Pitcairn Co. Boosts Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Pitcairn Co. lifted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 6.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,840 shares of the company’s stock after purchasing an additional 225 shares during the quarter. Pitcairn Co.’s holdings in Addus HomeCare were worth $397,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Principal Securities Inc. bought a new stake in Addus HomeCare during the fourth quarter worth about $26,000. GAMMA Investing LLC purchased a new stake in Addus HomeCare in the fourth quarter worth approximately $34,000. Assetmark Inc. grew its position in Addus HomeCare by 33.3% during the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock valued at $165,000 after acquiring an additional 443 shares during the last quarter. Envestnet Portfolio Solutions Inc. purchased a new position in shares of Addus HomeCare during the fourth quarter worth approximately $214,000. Finally, Cetera Trust Company N.A bought a new stake in Addus HomeCare in the fourth quarter worth $219,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Down 2.1 %

Addus HomeCare stock traded down $2.55 during mid-day trading on Thursday, reaching $121.12. The stock had a trading volume of 254,584 shares, compared to its average volume of 134,438. The company has a market capitalization of $2.19 billion, a price-to-earnings ratio of 30.43, a PEG ratio of 2.34 and a beta of 1.01. The company has a 50-day moving average price of $116.48 and a two-hundred day moving average price of $103.14. Addus HomeCare Co. has a one year low of $78.35 and a one year high of $124.48. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. Addus HomeCare’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.84 EPS. On average, analysts expect that Addus HomeCare Co. will post 4.36 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,186,500.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 4.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on ADUS shares. Bank of America lifted their target price on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. Macquarie assumed coverage on Addus HomeCare in a research report on Friday, June 28th. They set an “outperform” rating and a $136.00 price objective on the stock. TD Cowen increased their target price on Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a research report on Tuesday, June 18th. Oppenheimer lifted their price target on Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research report on Friday, June 7th. Finally, StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. One research analyst has rated the stock with a sell rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $116.25.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.